Search

everythinglearnresearchcommunity

for

Search:↓

The reviewers suggest clarifying the abstract, adding background on inflammation's effect on stem cells and cancer, discussing immune cells' role in tumors, and considering inflammation's potential to reduce cancer growth.

Neurons and synapses are key to brain function and learning.

Cerebronal® may help improve certain brain health markers.

Pregnancy and nursing increase certain brain activities in rats, but these changes disappear when the babies are taken away.

Rational design strategies are crucial for developing effective nanozymes for anti-inflammatory uses.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

Transcranial electrical stimulation may help reduce certain immune markers in COVID-19 patients.

Higher inflammation markers are linked to more severe alopecia areata.

Dimethyl fumarate speeds up wound healing in IL-36Ra deficient mice by reducing NET formation and oxidative stress.

Progesterone and its metabolites affect myelin protein expression differently in male and female rat Schwann cells.

Gut microbes significantly affect brain steroid levels.

Certain mice without specific receptors or mast cells don't lose hair from stress.

Researchers created a new method to measure brain steroids, finding higher levels of certain steroids and changes due to a drug.

TTNPB helps turn stem cells into neural stem cells, improving depression-like behaviors in rats.

Iron deficiency is not more common in women with hair loss, and neurogenic rosacea may need different treatment.

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

Emotional factors are crucial in treating and preventing scalp neurodermatitis and hair loss.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

Stress and alcohol affect brain chemicals differently in rats, mice, and humans, influenced by genetic differences.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Trichodynia is a painful scalp condition linked to hair loss and mental health issues, with limited treatment options.

Type 1/17 inflammation in psoriasis increases skin cell growth due to a molecule that could be a new treatment target.

Neurosteroids show promise for treating epilepsy and more research is needed.

IL-1 promotes fat cell growth in skin, while WNT inhibits it and encourages scar formation.

Neuroendocrine paraneoplastic syndromes often show skin changes, helping early diagnosis and requiring a team approach for best care.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Steroid treatment improved both gut and nerve symptoms in a man with Cronkhite–Canada syndrome.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.